Clinical characteristics of male and female korean patients with systemic lupus erythematosus: a comparative study

Korean Journal of Internal Medicine

Volumn 30, Issue 2, 2015, Pages 242-249

  Hwang, Jiwon ^a   Lee, Jaejoon ^a   Ahn, Joong Kyoung ^a   Park, Eun Jung ^b   Cha, Hoon Suk ^a   Koh, Eun Mi ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

Author keywords

Male; Nephritis; Outcome; Sex; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE DURATION; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HUMAN; KOREAN (PEOPLE); LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS AMERICAN COLLEGE OF RHEUMATOLOGY DAMAGE INDEX; ASIAN CONTINENTAL ANCESTRY GROUP; EPIDEMIOLOGY; ETHNOLOGY; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PROGNOSIS; RISK FACTOR; SOUTH KOREA; TERTIARY CARE CENTER; TIME FACTOR; YOUNG ADULT;

IMMUNOSUPPRESSIVE AGENT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PROGNOSIS; RENAL DIALYSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TERTIARY CARE CENTERS; TIME FACTORS; YOUNG ADULT;

EID: 84924419350     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2015.30.2.242     Document Type: Article

References (22)

1. Mok CC, Lau CS, Chan TM, Wong RW. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 1999;8:188-196.
2. Aranow C, Del Guidice J, Barland P, Weinstein A. Systemic lupus erythematosus disease severity in men and women: a case-control study. J Rheumatol 2002;29:1674-1677.
3. Soto ME, Vallejo M, Guillen F, Simon JA, Arena E, Reyes PA. Gender impact in systemic lupus erythematosus. Clin Exp Rheumatol 2004;22:713-721.
4. Garcia MA, Marcos JC, Marcos AI, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 2005;14:938-946.
5. Chang DM, Chang CC, Kuo SY, Chu SJ, Chang ML. The clinical features and prognosis of male lupus in Taiwan. Lupus 1998;7:462-468.
6. Chung WK, Oh YK, Na KY, et al. The clinical and pathologic features of lupus nephritis in male. Korean J Nephrol 1994;13:879-886.
7. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
9. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-369.
10. Tateno S, Hiki Y, Hamaguchi K, Tsuchida H, Shigematsu H, Kobayashi Y. Study of lupus nephritis in males. Q J Med 1991;81:1031-1039.
11. Koh WH, Fong KY, Boey ML, Feng PH. Systemic lupus erythematosus in 61 Oriental males: a study of clinical and laboratory manifestations. Br J Rheumatol 1994;33:339-342.
12. Andrade RM, Alarcon GS, Fernandez M, et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV: results from a multiethnic US cohort. Arthritis Rheum 2007;56:622-630.
13. Mongkoltanatus J, Wangkaew S, Kasitanon N, Louthrenoo W. Clinical features of Thai male lupus: an age-matched controlled study. Rheumatol Int 2008;28:339-344.
14. de Carvalho JF, do Nascimento AP, Testagrossa LA, Barros RT, Bonfa E. Male gender results in more severe lupus nephritis. Rheumatol Int 2010;30:1311-1315.
15. Halimi JM, Giraudeau B, Vol S, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000;58:1285-1292.
16. Orth SR, Stockmann A, Conradt C, et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998;54:926-931.
17. Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998;16:261-292.
18. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008;8:34-47.
19. Yun HR, Koh HK, Kim SS, et al. FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients. Lupus 2001;10:466-472.
20. Yap SN, Phipps ME, Manivasagar M, Tan SY, Bosco JJ. Human Fc gamma receptor IIA (FcgammaRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia. Lupus 1999;8:305-310.
21. Botto M, Theodoridis E, Thompson EM, et al. Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol 1996;104:264-268.
22. Ha Y, Lee KH, Jung S, Lee SW, Lee SK, Park YB. Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy. Lupus 2011;20:1027-1034.